Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

Human skin models are essential for studying skin's sensory, immune, and nervous system interactions.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Immune therapy for cancer can cause hair loss scars in some patients.

The skin's immune system helps it regenerate and fight infections.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Multiomics is revolutionizing biology by enabling breakthroughs in research and disease diagnosis.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.

Entospletinib effectively prevents eye and skin GVHD in mice.

SLE patients need careful diagnosis to distinguish infections from disease flares for proper treatment.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Controlling immune responses with biomaterials can reduce scarring and improve skin regeneration.

Blocking certain proteins on immune cells may help treat alopecia areata.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Rabies virus was found in specific skin cells of rabid dogs' muzzles, suggesting these cells could help diagnose rabies.

Sun-exposed skin shows different cell activity and gene expression, suggesting targets to prevent skin aging and cancer.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.